- CSR Summary Not Yet Available
- NCT00473512
- Primary Citation Not Available
Trial Information
Generic NameAbiraterone acetateProduct NameZYTIGA®Therapeutic AreaCancers and Other NeoplasmsEnrollment54% FemaleN/A% WhiteN/A
Product ClassHormonesSponsor Protocol NumberCOU-AA-001Data PartnerJohnson & JohnsonCondition StudiedNeoplasms, ProstaticMean/Median Age (Years)69.9
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available